Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas

Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas

Head and neck squamous cell carcinomas (HNSCCs) are the most common cancers of the head and neck, and their prevalence is rapidly increasing. HNSCCs present a clinical challenge because of their high recurrence rate, therapeutic resistance to radiation and chemotherapy drugs, and adverse effects. He...

Full description

Bibliographic Details
Main Authors: Cheng-Ming Hsu, Ming-Yu Yang, Ming-Shao Tsai, Geng-He Chang, Yao-Hsu Yang, Yao-Te Tsai, Ching-Yuan Wu, Shun-Fu Chang
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
head and neck squamous cell carcinoma
danshen
<i>Salvia miltiorrhiza</i>
dihydroisotanshinone I
apoptosis
p38 signaling
Online Access:https://www.mdpi.com/1422-0067/22/16/8881

Similar Items

Similar Items